Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Appl Opt ; 61(16): 4761-4767, 2022 Jun 01.
Article in English | MEDLINE | ID: mdl-36255957

ABSTRACT

It is a challenge to perform simple and rapid detection of substances due to their complex structure. Biochemical molecules play a vital role in human health and environmental testing. Surface-enhanced Raman scattering (SERS) detection has the characteristics of strong specificity and real-time performance. At present, most SERS systems are expensive and not portable. Here, we demonstrate a SERS detection system with all-fiber connection, combined with a microfluidic chip and micro-lenses. Compared with the conventional SERS system that uses the spatial optical path, the devices in our system are connected by optical fibers, making the system more stable and operable. Besides, the microfluidic chips are introduced to further improve the system integration and stability. Owing to the micro-lensed fiber probe, the detected Raman signal intensity is increased by 2-3 times. We anticipate that the presented work will lead toward a rapid and portable SERS system and corresponding detection system. It also lays the foundation for real-time recognition in various complex environments in the design of a future optical fiber system.


Subject(s)
Microfluidics , Spectrum Analysis, Raman , Humans , Optical Fibers
2.
Appl Opt ; 60(22): 6503-6510, 2021 Aug 01.
Article in English | MEDLINE | ID: mdl-34612887

ABSTRACT

We present a high-precision, low-cost demodulation method for the fiber Bragg grating (FBG) using a thermal-induced chirp and a shallow neural network. The thermal-induced chirp of a semiconductor laser generates the different wavelength components in a single pulse, which will form an exponential function echo signal after being reflected by the FBG. By learning the shape of the reflected light, the back-propagation neural network can simultaneously demodulate the sensing temperature and laser power. The whole detection system has only a few basic detection devices, which makes it low cost. The experimental results show that the multivision demodulation (MVD) method can reach a high demodulation precision of 0.35°C. We believe these results indicate the MVD method is an outstanding scheme in the field of FBG interrogation.

3.
Appl Opt ; 59(3): 748-755, 2020 Jan 20.
Article in English | MEDLINE | ID: mdl-32225205

ABSTRACT

We design and theoretically investigate a surface-enhanced Raman scattering (SERS) sensor based on the hybrid plasmonic grating slot waveguide. The sensor is formed by combining a dielectric deep slot waveguide and a metallic grating slot waveguide. The proposed sensor exhibits a high field enhancement with a maximum enhancement factor of 7580.9 at the wavelength of 785 nm, revealing that the electric field in such hybrid plasmonic grating slot waveguide can be extremely strengthened. To better characterize the performance of the sensor in the SERS application, the total normalized volumetric enhancement factor (TNVEF) is proposed, which is determined by both the |E|4-approximation-based volumetric field enhancement and Raman scattered light collection efficiency. The TNVEF is utilized to characterize the influences of the structural parameters on the sensor and further optimize the sensing structure. Such on-chip SERS sensor can be integrated with a micro-laser and a micro-multiplexer on a photonic platform to realize an all-integrated on-chip SERS detection system.

5.
J Clin Microbiol ; 44(8): 2890-6, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16891508

ABSTRACT

We studied two large Mycobacterium tuberculosis genotype clusters associated with recent outbreaks in homeless persons to determine factors associated with these tuberculosis (TB) strains. Isolates from all culture-positive TB cases diagnosed from 1 January 2001 to 31 December 2004 were genotyped. Patients whose isolates had identical restriction fragment length polymorphism patterns and spoligotypes were considered clustered. Health department records were reviewed and reinterviews attempted for clustered cases. Patients with the Cs30 and BEs75 strains were compared to other genotypically clustered cases and to each other. The two largest genotype clusters among homeless persons were the Cs30 strain (n = 105) and the BEs75 strain (n = 47). Fifty-one (49%) patients with the Cs30 strain and 28 (60%) with the BEs75 strain were homeless. Compared to patients with the BEs75 strain, patients with the Cs30 strain were less likely to be respiratory acid-fast bacillus smear positive (51% versus 72%). Furthermore, patients with the BEs75 strain were more likely to be HIV infected (74% versus 42%), which suggests that most patients with this strain advanced to disease after recent infection. Cases in clusters of strains that have been circulating in the community over a long time period, such as the Cs30 strain, require additional investigation to determine whether clustering is a result of recent transmission or reactivation of remote infection.


Subject(s)
Ill-Housed Persons , Mycobacterium tuberculosis/classification , Mycobacterium tuberculosis/genetics , Tuberculosis/epidemiology , Tuberculosis/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Cluster Analysis , DNA Fingerprinting , DNA, Bacterial/genetics , Disease Outbreaks , Female , Genotype , HIV Infections/complications , Humans , Infant , Male , Middle Aged , Molecular Epidemiology , Mycobacterium tuberculosis/isolation & purification , New York City/epidemiology , Polymorphism, Restriction Fragment Length , Sputum/microbiology
6.
Am J Epidemiol ; 164(1): 21-31, 2006 Jul 01.
Article in English | MEDLINE | ID: mdl-16641308

ABSTRACT

Factors influencing tuberculosis cluster growth are poorly understood. The authors examined clusters of two or more culture-confirmed Mycobacterium tuberculosis cases between January 1, 2001, and December 31, 2003, that had insertion sequence 6110 (IS6110) restriction fragment length polymorphism and spoligotype patterns identical to those of another study case. Genotypes first seen in New York, New York, before or during 1993 were considered historical; recent strains were those first seen after 1993. The authors examined the effect of the combined characteristics of infectiousness of the first two cases in a cluster on the rate of cluster growth. Genotyping was performed for 2,408 (91.8%) of the 2,623 tuberculosis cases diagnosed; 873 cases were in 212 clusters. Thirty-one clusters had historical strains, 153 were recent, and 28 were of unknown period. Patients' infectiousness was not associated with the rate of cluster growth among historical strain clusters. Among recent strain clusters, infectiousness of both of the initial cases was associated with a higher rate of cluster growth compared with clusters in which neither initial case was infectious, upon adjustment for male sex (rate ratio = 2.62, 95% confidence interval: 1.19, 5.78). The rate of genotype cluster growth should be monitored regardless of how long the strain has been present in the community. However, infectiousness in the first two cases may be useful to prioritize genotype cluster investigations.


Subject(s)
Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/pathogenicity , Tuberculosis/epidemiology , Tuberculosis/microbiology , Urban Health , AIDS-Related Opportunistic Infections/epidemiology , Child , Child, Preschool , Cluster Analysis , Comorbidity , Contact Tracing , Female , Genotype , Humans , Male , New York City/epidemiology , Polymorphism, Restriction Fragment Length , Population Surveillance/methods , Risk Assessment , Risk Factors
7.
Emerg Infect Dis ; 12(5): 719-24, 2006 May.
Article in English | MEDLINE | ID: mdl-16704826

ABSTRACT

In 2001, New York City implemented genotyping to its tuberculosis (TB) control activities by using IS6110 restriction fragment length polymorphism (RFLP) and spoligotyping to type isolates from culture-positive TB patients. Results are used to identify previously unknown links among genotypically clustered patients, unidentified sites of transmission, and potential false-positive cultures. From 2001 to 2003, spoligotype and IS6110-based RFLP results were obtained for 90.7% of eligible and 93.7% of submitted isolates. Fifty-nine (2.4%) of 2,437 patient isolates had false-positive culture results, and 205 genotype clusters were identified, with 2-81 cases per cluster. Cluster investigations yielded 57 additional links and 17 additional sites of transmission. Four additional TB cases were identified as a result of case finding initiated through cluster investigations. Length of unnecessary treatment decreased among patients with false-positive cultures.


Subject(s)
Mycobacterium tuberculosis/classification , Mycobacterium tuberculosis/genetics , Polymorphism, Restriction Fragment Length , Tuberculosis/microbiology , Bacterial Typing Techniques , Cluster Analysis , Cross Infection/prevention & control , False Positive Reactions , Genotype , Humans , Mycobacterium tuberculosis/isolation & purification , New York City/epidemiology , Tuberculosis/epidemiology , Tuberculosis/prevention & control , Tuberculosis/transmission , Tuberculosis, Multidrug-Resistant/epidemiology , Tuberculosis, Multidrug-Resistant/microbiology , Tuberculosis, Multidrug-Resistant/prevention & control
8.
Infect Immun ; 71(4): 2058-64, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12654826

ABSTRACT

Tuberculosis is the seventh leading cause of morbidity and mortality in the world, with eight million cases per year. Animal and human studies demonstrate an enrichment of CD4 cells at sites of disease, with a more favorable clinical course when there is a Th1 response with the presence of gamma interferon (IFN-gamma). We previously treated patients who had multidrug-resistant tuberculosis with recombinant IFN-gamma (rIFN-gamma) in aerosol form and were able to convert smear-positive cases to smear negative with 12 treatments over 1 month. We hypothesized that rIFN-gamma would induce signal transducer and activator of transcription (STAT) and interferon regulatory factor (IRF) binding activity in alveolar macrophages (AM). AM treated in vitro showed clear upregulation of STAT-1 and IRF-1 by rIFN-gamma. STAT-1 was not activated and IRF-1 was only weakly induced after 1 day of infection by Mycobacterium tuberculosis TN913. In bronchoalveolar lavage (BAL) cells obtained from 10 of 10 tuberculosis patients 10 +/- 2 days post-antituberculosis treatment, there was no detectable STAT-1 or IRF-1 DNA-binding activity. After 4 weeks of treatment with rIFN-gamma aerosol in addition to the antituberculosis drugs, 10 of 10 patients had increased STAT-1, IRF-1, and/or IRF-9 DNA-binding activity in BAL cells from lung segments shown radiographically to be involved and in those shown to be uninvolved. Symptoms and chest radiographs improved, and amounts of macrophage inflammatory cytokines and human immunodeficiency virus type 1 (HIV-1) viral loads (in five of five HIV-1-coinfected patients) declined in the second BAL specimens. rIFN-gamma aerosol induces signal transduction and gene expression in BAL cells and should be evaluated for efficacy in a randomized, controlled clinical trial.


Subject(s)
Gene Expression Regulation/drug effects , Interferon-gamma/pharmacology , Macrophages, Alveolar/drug effects , Signal Transduction/drug effects , Tuberculosis, Pulmonary/drug therapy , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/microbiology , Adult , Bronchoalveolar Lavage Fluid/cytology , Bronchoalveolar Lavage Fluid/immunology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Female , HIV Infections/complications , Humans , Interferon Regulatory Factor-1 , Interferon-Stimulated Gene Factor 3 , Interferon-Stimulated Gene Factor 3, gamma Subunit , Interferon-gamma/administration & dosage , Interferon-gamma/therapeutic use , Macrophages, Alveolar/immunology , Macrophages, Alveolar/microbiology , Male , Middle Aged , Mycobacterium tuberculosis , Phosphoproteins/genetics , Phosphoproteins/metabolism , Recombinant Proteins , STAT1 Transcription Factor , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Treatment Outcome , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL